Page last updated: 2024-10-22

amsacrine and Phlebitis

amsacrine has been researched along with Phlebitis in 5 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Phlebitis: Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS).

Research Excerpts

ExcerptRelevanceReference
"Amsacrine (AMSA) was a high effective medicine of acute leukemia treatment."7.69[Venous protection of acute leukemia treatment with amsacrine]. ( Hong, J; Ma, XJ; Xiang, YM, 1996)
"In a phase II study 20 patients with measurable metastatic melanoma were treated with amsacrine 120 mg/m2 every 3 weeks."7.67Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene. ( Bishop, J; Coates, AS; Mann, GJ; Raghavan, D, 1986)
"The ultimate aim of this study was to develop asulacrine (ASL)-loaded long-circulating liposomes to prevent phlebitis during intravenous (i."3.81Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation. ( Amirapu, S; Baguley, BC; Liu, J; See, E; Shaw, JP; Wang, G; Wu, Z; Zhang, W, 2015)
"Amsacrine (AMSA) was a high effective medicine of acute leukemia treatment."3.69[Venous protection of acute leukemia treatment with amsacrine]. ( Hong, J; Ma, XJ; Xiang, YM, 1996)
"In a phase II study 20 patients with measurable metastatic melanoma were treated with amsacrine 120 mg/m2 every 3 weeks."3.67Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene. ( Bishop, J; Coates, AS; Mann, GJ; Raghavan, D, 1986)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, W1
Wang, G1
See, E1
Shaw, JP1
Baguley, BC1
Liu, J1
Amirapu, S1
Wu, Z1
Micetich, KC1
Zwelling, LA1
Gormley, P1
Young, RC1
Issell, BF1
Ma, XJ1
Xiang, YM1
Hong, J1
Coates, AS1
Bishop, J1
Mann, GJ1
Raghavan, D1

Other Studies

5 other studies available for amsacrine and Phlebitis

ArticleYear
Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Apr-10, Volume: 203

    Topics: Amsacrine; Animals; Antineoplastic Agents; Chemical Precipitation; Infusion Pumps; Injections; Lipos

2015
Phase I-II study of m-AMSA administered as a continuous infusion.
    Cancer treatment reports, 1982, Volume: 66, Issue:10

    Topics: Aminoacridines; Amsacrine; Antineoplastic Agents; Bone Marrow; Drug Evaluation; Female; Humans; Kine

1982
Amsacrine (AMSA).
    Cancer treatment reviews, 1980, Volume: 7, Issue:2

    Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Breast Neoplasms; Dogs; Dose-Response Rel

1980
[Venous protection of acute leukemia treatment with amsacrine].
    Zhonghua hu li za zhi = Chinese journal of nursing, 1996, Volume: 31, Issue:9

    Topics: Acute Disease; Amsacrine; Antineoplastic Agents; Fluid Therapy; Humans; Leukemia; Phlebitis

1996
Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:1

    Topics: Aminoacridines; Amsacrine; Anthracenes; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Fema

1986